1-9 of 9
Florian Heidel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characterization of TREM-1 Signaling in Human Neutrophils By Kinome Array and RNA-Seq

Frederic Ries, Matthias Klein, Nora Sophia Lindhauer, Sophie Többen, Florian Heidel, Markus P. Radsak
Journal: Blood
Blood (2023) 142 (Supplement 1): 3913.
https://doi.org/10.1182/blood-2023-178717
Published: 2023
Journal Articles

Firstline Treatment with Ruxolitinib Versus Best Available Therapy in Patients with Polycythemia Vera: Pre-Specified Interim Analysis of the Randomized Phase 2b Ruxobeat Clinical Trial of the German Study Group for Myeloproliferative Neoplasms (GSG-MPN)

Steffen Koschmieder, Susanne Isfort, Lino L. Teichmann, Philippe Schafhausen, Florian Heidel, Andreas Hochhaus, Martin Griesshammer, Katja Sockel, Philipp Jost, Denise Wolleschak, Konstanze Döhner, Joachim R. Goethert, Markus P. Radsak, Marinela Augustin, Heiko Becker, Aristoteles Giagounidis, Markus Schaich, Martine Klausmann, Nikolas Von Bubnoff, Frank Stegelmann, Maike Kortmann, Julia Frank, Martin Hellmich, Tim H. Brümmendorf
Journal: Blood
Blood (2023) 142 (Supplement 1): 619.
https://doi.org/10.1182/blood-2023-173225
Published: 2023
Journal Articles

Neutrophil Functionalities in Patients with Paroxysmal Nocturnal Haemoglobinuria Are Not Affected By Complement C5- Inhibition

Nora Sophia Lindhauer, Cornelia Sabine Schmidt, Frederic Ries, Eva-Marie Fehr, Markus P. Radsak, Florian Heidel
Journal: Blood
Blood (2023) 142 (Supplement 1): 5646.
https://doi.org/10.1182/blood-2023-187076
Published: 2023
Journal Articles

Impact of Ruxolitinib-Response Feature on Outcome in Myelofibrosis: A Multicentre Study on 356 Patients

Giulia Benevolo, MD, Giuseppe A Palumbo, MD, Massimiliano Bonifacio, MD, Mario Tiribelli, MD, Maura Nicolosi, MD, Andrea Evangelista, Bruno Martino, Elisabetta Abruzzese, MD, Mariella D'adda, Nicola Polverelli, MD, Micaela Bergamaschi, MD, Alessandra Tieghi, MD, Francesco Cavazzini, MD, Adalberto Ibatici, MD, Monica Crugnola, MD, Costanza Bosi, MD, Roberto Latagliata, Lucia Catani, MD, Franco Aversa, MD, Francesco Di Raimondo, MD, Umberto Vitolo, MD, Roberto Massimo Lemoli, MD, Renato Fanin, MD, Francesco Merli, Antonio Cuneo, MD, Michele Cavo, MD, Massimo Breccia, MD PhD, Nicola Vianelli, MD, Florian Heidel, MD, Francesca Palandri, PhD MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1639.
https://doi.org/10.1182/blood.V130.Suppl_1.1639.1639
Published: 2017
Journal Articles

The JAK2 Kinase Inhibitor LS104 Induces Growth-Arrest and Apoptosis in JAK2V617F Positive Cells.

Daniel B. Lipka, MD, Linda S. Hoffmann, MSc, Florian Heidel, MD, Boyka Markova, PhD, Stefan Kasper, MD, Frank Breitenbuecher, PhD, Thomas Kindler, MD, Ross Levine, MD, Joseph Elliot, PhD, Christoph Huber, MD, Thomas Fischer, MD
Journal: Blood
Blood (2007) 110 (11): 3544.
https://doi.org/10.1182/blood.V110.11.3544.3544
Published: 2007
Journal Articles

A neoepitope generated by an FLT3 internal tandem duplication ( FLT3-ITD ) is recognized by leukemia-reactive autologous CD8 + T cells

Brief Report
Claudine Graf, Florian Heidel, Stefan Tenzer, Markus P. Radsak, Fian K. Solem, Cedrik M. Britten, Christoph Huber, Thomas Fischer, Thomas Wölfel
Journal: Blood
Blood (2006) 109 (7): 2985–2988.
https://doi.org/10.1182/blood-2006-07-032839
Published: 2006
Includes: Supplemental data
Journal Articles

Bis(1 H -indol-2yl)methanones Are Effective Inhibitors of Mutated FLT3 Tyrosine Kinase, Overcome Resistance to PKC412A In Vitro and Show Synergy with Chemotherapy.

Florian Heidel, Fian K. Mirea, Frank Breitenbucher, Stefan Dove, Christoph Huber, Frank D. Bohmer, Thomas Fischer
Journal: Blood
Blood (2006) 108 (11): 1369.
https://doi.org/10.1182/blood.V108.11.1369.1369
Published: 2006
Journal Articles

Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domain

Clinical Trials & Observations
Florian Heidel, Fian K. Solem, Frank Breitenbuecher, Daniel B. Lipka, Stefan Kasper, M. H. Thiede, Christian Brandts, Hubert Serve, Johannes Roesel, Francis Giles, Eric Feldman, Gerhard Ehninger, Gary J. Schiller, Stephen Nimer, Richard M. Stone, Yanfeng Wang, Thomas Kindler, Pamela S. Cohen, Christoph Huber, Thomas Fischer
Journal: Blood
Blood (2006) 107 (1): 293–300.
https://doi.org/10.1182/blood-2005-06-2469
Published: 2006
Journal Articles

LS104, a Novel Kinase Inhibitor, Induces Apoptosis, Synergizes with Cytostatic Drugs and Is Targeting the Receptor Tyrosine Kinase FLT3.

Stefan Kasper, Thomas Kindler, MD, Florian Heidel, MD, Frank Breitenbuecher, PhD, Yvette Hoehn, MD, Daniel Lipka, Helmut Thomas, PhD, Christoph Huber, MD, Thomas Fischer, MD
Journal: Blood
Blood (2005) 106 (11): 3362.
https://doi.org/10.1182/blood.V106.11.3362.3362
Published: 2005